Prelude Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Prelude Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Buy
2024 Q2	–	Sell
2024 Q1	$403K	Buy
2020 Q4	–	Sell
2020 Q3	$2K	Buy
2020 Q1	–	Sell
2019 Q4	$222K	Buy